longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

DUALITYBIO-B

09606

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -9.77, below the reasonable range, cheaper than 80.46% of the time in the past 1 years, and the industry ranks 47/78, the industry Median -5.53.

-9.77xP/E
HK$178.20Stock price
HK$-18.23Earnings per share
-9.77xP/E
Stock priceHK$178.20Earnings per shareHK$-18.23

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-8.89x
Typical range
-9.76x–-6.78x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0159318477636

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
09926HKAKESO
-74.78x79.51%HK$83.27B
09688HKZAI LAB
-14.93x505.86%HK$22.04B
01877HKJUNSHI BIO
-37.67x84.85%HK$17.43B
07666HKMETIS TECHBIO-P
-40.04x96.70%HK$16.30B
09606HKDUALITYBIO-B
-9.77x83.47%HK$16.19B
02627HKAB&B BIO-TECH-B
-46.87x--HK$11.54B
06855HKASCENTAGE
-6.62x18.21%HK$11.20B
09887HKLEADS BIOLABS-B
-35.01x8.84%HK$10.76B
02595HKGENFLEET-B
-6.25x78.96%HK$9.47B
02493HKMABWELL-B
-8.51x--HK$9.21B
01952HKEVEREST MED
-148.18x324.61%HK$9.20B
06938HKRIBOLIFE-B
-44.54x29.88%HK$8.70B
01672HKASCLETIS-B
-12.73x78.59%HK$8.67B
02616HKCSTONE PHARMA-B
-17.19x1.96%HK$8.29B
09966HKALPHAMAB-B
-36.87x--HK$7.47B
02171HKCARSGEN-B
-72.51x51.12%HK$7.45B
01779HKLONGBIO-B
-29.87x--HK$7.43B
02335HKMICOT PHARMA-B
-16.62x37.50%HK$6.97B
06872HKTENNOR THERAP-B
-39.08x--HK$6.27B
02256HKABBISKO-B
-10.99x300.95%HK$5.91B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.